Deductive genomics: A functional approach to identify innovative drug targets in the post-genome era

American Journal of PharmacoGenomics

Volumn 2, Issue 4, 2002, Pages 263-271

  Stumm, Gabriele ^a   Russ, Andreas ^a   Nehls, Michael ^a  

^a Ingenium Pharmaceuticals AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; ANIMAL MODEL; CAENORHABDITIS ELEGANS; COST BENEFIT ANALYSIS; DROSOPHILA MELANOGASTER; DRUG IDENTIFICATION; DRUG SCREENING; DRUG TARGETING; EPILEPSY; GENE FUNCTION; GENE IDENTIFICATION; GENETIC VARIABILITY; HUMAN; HUMAN GENOME; MAMMALIAN GENETICS; MOLECULAR MODEL; MOUSE STRAIN; MULTIPLE SCLEROSIS; MUTATION; NEUROBIOLOGY; NEUROPSYCHIATRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; REVIEW; TRANSGENICS; ZEBRA FISH; ANIMAL; DRUG DELIVERY SYSTEM; GENOME; GENOMICS; METHODOLOGY;

ANIMALIA; CAENORHABDITIS; CAENORHABDITIS ELEGANS; DANIO RERIO; DROSOPHILA MELANOGASTER; MAMMALIA; MELANOGASTER;

ANIMALS; DRUG DELIVERY SYSTEMS; GENOME; GENOME, HUMAN; GENOMICS; HUMANS;

EID: 0036443984     PISSN: 11752203     EISSN: None     Source Type: Journal    
DOI: 10.2165/00129785-200202040-00006     Document Type: Review

References (75)

1. Edmunds RC, Ma PC, Tanio CP. Splicing a cost squeeze into the genomics revolution. McKinsey Q 2001; (2): 15-9
2. Lander ES. Linton LM, Birren B. et al. Initial sequencing and analysis of the human genome. Nature 2001; 409: 860-921
3. O'Neil NJ, Martin RL, Tomlinson ML. et al. RNA-mediated interference as a tool for identifying drug targets. Am J Pharmacogenomics 2001; 1: 45-53
4. Haffter P, Granato M, Brand M. et al. The identification of genes with unique and essential functions in the development of the zebrafish, Danio rerio. Development 1996; 123: 1-36
5. Gaul U, Chang H, Choi T, et al. Identification of ras targets using a genetic approach. Ciba Found Symp 1993; 176: 85-92
6. Dickson B, Hafen E. Genetics of signal transduction in invertebrates. Curr Opin Genet Dev 1994; 4 (1): 64-70
7. Woods IG, Kelly PD, Chu F, et al. A comparative map of the zebrafish genome. Genome Res 2000; 10 (12): 1903-14
8. Postlethwait JH, Woods IG, Ngo-Hazelett P, et al. Zebrafish comparative genomics and the origins of vertebrate chromosomes. Genome Res 2000; 10 (12): 1890-902
9. Lander ES. Linton LM, Birren B, et al. Initial sequencing and analysis of the human genome. Nature 2001; 409 (6822): 860-921
10. Russell WL, Kelly EM, Hunsicker PR, et al. Specific-locus test shows ethylnitrosourea to be the most potent mutagen in the mouse. Proc Natl Acad Sci U S A. 1979 Nov; 76 (11): 5818-9
11. Rinchik EM, Carpenter DA. N-ethyl-N-nitrosourea mutagenesis of a 6- to 11-cM subregion of the Fah-Hbb interval of mouse chromosome 7: Completed testing of 4557 gametes and deletion mapping and complementation analysis of 31 mutations. Genetics 1999; 152 (1): 373-83
12. Vitaterna MH, King DP, Chang AM, et al. Mutagenesis and mapping of a mouse gene. Clock, essential for circadian behavior. Science 1994; 264 (5159): 719-25
13. Su LK. Kinzler KW, Vogelstein B. et al. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 1992; 256 (5057): 668-70
14. Hrabe de Angelis MH, Flaswinkel H, Fuchs H. et al. Genome-wide, large-scale production of mutant mice by ENU mutagenesis. Nat Genet 2000; 25 (4): 444-7
15. Nolan PM, Peters J, Strivens M, et al. A systematic, genome-wide, phenotype. driven mutagenesis programme for gene function studies in the mouse. Nat Genet 2000; 25 (4): 440-3
16. Nehls M, Kyewski B, Messerle M, et al. Two genetically separable steps in the differentiation of thymic epithelium. Science 1996; 272 (5263): 886-9
17. Schlake T, Schorpp M. Nehls M, et al. The nude gene encodes a sequence-specific DNA binding protein with homologs in organisms that lack an anticipatory immune system. Proc Natl Acad Sci U S A 1997; 94 (8): 3842-7
18. Nehls M, Pfeifer D. Schorpp M. et al. New member of the winged-helix protein family disrupted in mouse and rat nude mutations. Nature 1994; 372 (6501): 103-7
19. Riordan JR. Rommens JM, Kerem B, et al. Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA. Science 1989; 245 (4922): 1066-73
20. Rommens JM, Iannuzzi MC. Kerem B. et al. Identification of the cystic fibrosis gene: Chromosome walking and jumping. Science 1989; 245 (4922): 1059-65
21. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell 1993; 72 (6): 971-83
22. Savitsky K, Bar-Shira A, Gilad S, et al. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 1995; 268 (5218): 1749-53
23. Lopez AD. Murray CC. The global burden of disease. 1990-2020. Nat Med 1998; 4 (11): 1241-3
24. Aalto-Setala T, Marttunen M, Tuulio-Henriksson A, et al. One-month prevalence of depression and other DSM-IV disorders among young adults. Psychol Med 2001; 31 (5): 791-801
25. Gliatto MF. Generalized anxiety disorder. Am Fam Physician 2000; 62 (7): 1591-602
26. Parikh SV, Lam RW. Clinical guidelines for the treatment of depressive disorders: I. Definitions, prevalence, and health burden. Can J Psychiatry 2001: 46 Suppl. 1: 13S-20S
27. Krystal JH, D'Souza DC, Sanacora G, et al. Current perspectives on the pathophysiology of schizophrenia, depression, and anxiety disorders. Med Clin North Am 2001: 85 (3): 559-77
28. Allison DB, Casey DE. Antipsychotic-induced weight gain: A review of the literature. J Clin Psychiatry 2001; 62 Suppl. 7: 22-31
29. Bech P, Social aspects of treatment of depression. Int Clin Psychopharmacol 1995; 10 Suppl. 1: 11-4
30. Bourin M, Chue P, Guillon Y. Paroxetine: A review. CNS Drug Rev 2001; 7 (1): 25-47
31. Marder SR. Facilitating compliance with antipsychotic medication. J Clin Psychiatry 1998; 59 Suppl. 3: 21-5
32. Ploix C, Spier AD. Fighting Bax: Towards a Parkinson's disease therapy. Trends Neurosci 2001; 24 (5): 255
33. Hely MA, Fung VS, Morris JG. Treatment of Parkinson's disease. J Clin Neurosci 2000; 7 (6): 484-94
34. Rowland LP, Shneider NA. Amyotrophic lateral sclerosis. N Engl J Med 2001; 344 (22): 1688-700
35. Bjartmar C, Trapp BD. Axonal and neuronal degeneration in multiple sclerosis: Mechanisms and functional consequences. Curr Opin Curr Opin Neurol 2001; 14(3): 271-8
36. Julien JP. Amyotrophic lateral sclerosis, unfolding the toxicity of the misfolded. Cell 2001; 104 (4): 581-91
37. Alexi T, Borlongan CV, Faull RL, et al. Neuroprotective strategies for basal ganglia degeneration: Parkinson's and Huntington's diseases. Prog Neurobiol 2000; 60 (5): 409-70
38. Skaper SD, Walsh FS. Neurotrophic molecules: Strategies for designing effective therapeutic molecules in neurodegeneration. Mol Cell Neurosci 1998; 12 (4-5): 179-93
39. Baekelandt V, De Strooper B, Nuttin B, et al. Gene therapeutic strategies for neurodegenerative diseases, Curr Opin Mol Ther 2000; 2 (5): 540-54
40. Wingerchuk DM, Weinshenker BG. Multiple sclerosis: Epidemiology, genetics, classification, natural history, and clinical outcome measures. Neuroimaging Clin N Am 2000; 10 (4): 611-24
41. Gardiner RM. Genetic basis of the human epilepsies. Epilepsy Res 1999; 36 (2-3): 91-5
42. Trask PC, Esper P, Riba M, et al. Psychiatric side effects of interferon therapy: Prevalence, proposed mechanisms, and future directions. J Clin Oncol 2000; 18 (11): 2316-26
43. Pellock JM. Treatment of epilepsy in the new millennium. Pharmacotherapy 2000; 20 (8 Pt 2): 129S-38S
44. Greenwald IS, Sternberg PW, Horvitz HR. The lin-12 locus specifies cell fates in Caenorhabditis elegans. Cell 1983; 34 (2): 435-44
45. Levitan D, Greenwald I. Effects of SEL-12 presenilin on LIN-12 localization and function in Caenorhabditis elegans. Development 1998; 125 (18): 3599-606
46. Li X, Greenwald I. HOP-1, a Caenorhabditis elegans presenilin, appears to be functionally redundant with SEL-12 presenilin and to facilitate LIN-12 and GLP-1 signaling. Proc Natl Acad Sci U S A 1997; 94 (22): 12204-9
47. Struhl G. Fitzgerald K, Greenwald I. Intrinsic activity of the Lin-12 and Notch intracellular domains in vivo. Cell 1993; 74 (2): 331-45
48. Sisodia SS. St George-Hyslop PH. Gamma-secretase, Notch, Amyloid B and Alzheimers disease. Where do the presinilins fit in? Nat Rev Neurosci 2002; 3: 281-90
49. Baker K, Salkoff L. The Drosophila Shaker gene codes for a distinctive K+ current in a subset of neurons. Neuron 1990; 4 (1): 129-40
50. Kamb A, Iverson LE, Tanouye MA. Molecular characterization of Shaker, a Drosophila gene that encodes a potassium channel. Cell 1987; 50 (3): 405-13
51. Felix R. Channelopathies: Ion channel defects linked to heritable clinical disorders. J Med Genet 2000; 37 (10): 729-40
52. Papazian DM, Schwarz TL, Tempel BL, et al. Cloning of genomic and complementary DNA from Shaker, a putative potassium channel gene from Drosophila. Science 1987; 237 (4816): 749-53
53. De Stasio EA, Dorman S. Optimization of ENU mutagenesis of Caenorhabditis elegans. Mutat Res 2001; 495 (1-2): 81-8
54. Nivard MJ, Pastink A, Vogel EW. Molecular analysis of mutations induced in the vermilion gene of Drosophila melanogaster by methyl methanesulfonate. Genetics 1992; 131 (3): 673-82
55. Fossett NG, Arbour-Reily P, Kilroy G. et al. Analysis of ENU-induced mutations at the Adh locus in Drosophila melanogaster. Mutat Res 1990; 231 (1): 73-85
56. Burgess DL, Jones JM, Meisler MH, et al. Mutation of the Ca2+ channel beta subunit gene Cchb4 is associated with ataxia and seizures in the lethargic (lh) mouse. Cell 1997; 88 (3): 385-92
57. Burgess DL, Noebels JL. Single gene defects in mice: The role of voltage-dependent calcium channels in absence models. Epilepsy Res 1999; 36 (2-3): 111-22
58. Noebels JL, Qiao X, Bronson RT, et al. Stargazer: A new neurological mutant on chromosome 15 in the mouse with prolonged cortical seizures. Epilepsy Res 1990; 7 (2): 129-35
59. Escayg A, Jones JM. Kearney JA, et al. Calcium channel beta 4 (CACNB4): Human ortholog of the mouse epilepsy gene lethargic. Genomics 1998: 50 (1): 14-22
60. Hosford DA, Lin FH, Wang Y, et al. Studies of the lethargic (lh/lh) mouse model of absence seizures: Regulatory mechanisms and identification of the Ih gene. Adv Neurol 1999: 79: 239-52
61. Rho JM, Szot P, Tempel BL, et al. Developmental seizure susceptibility of kv 1.1 potassium channel knockout mice. Dev Neurosci 1999; 21 (3-5): 320-7
62. Letts VA, Felix R, Biddlecome GH, et al. The mouse stargazer gene encodes a neuronal Ca2+-channel gamma subunit. Nat Genet 1998; 19 (4): 340-7
63. Jin W, Sugaya A. Tsuda T, et al. Relationship between large conductance calcium-activated potassium channel and bursting activity. Brain Res 2000; 860 (1-2): 21-8
64. Hallmann K, Durner M, Sander T, et al. Mutation analysis of the inwardly rectifying K (+) channels KCNJ6 (GIRK2) and KCNJ3 (GIRKI) in juvenile myoclonic epilepsy. Am J Med Genet 2000: 96 (1): 8-11
65. Steinlein OK, Noebels JL. Ion channels and epilepsy in man and mouse. Curr Opin Genet Dev 2000; 10 (3): 286-91
66. Chevassus-au-Louis N, Baraban SC, Gaiarsa JL, et al. Cortical malformations and epilepsy: New insights from animal models. Epilepsia 1999; 40: 811-21
67. Barclay J, Balaguero N, Mione M, et al. Ducky mouse phenotype of epilepsy and ataxia is associated with mutations in the Cacna2d2 gene and decreased calcium channel current in cerebellar Purkinje cells. J Neurosci 2001; 21: 6095-104
68. Kearney JA, Plummer NW, Smith MR, et al, A gain-of-function mutation in the sodium channel gene Scn2a results in seizures and behavioral abnormalities. Neuroscience 2001; 102: 307-17
69. Ferraro TN, Golden GT, Smith GG, et al. Mapping loci for pentylenetetrazol-induced seizure susceptibility in mice. J Neurosci 1999; 19: 6733-9
70. Skradski SL, Clark AM, Jiang H, et al. A nocel gene causing a mendelian audiogenic mouse epilepsy. Neuron 2001; 31: 537-44
71. Hallmann K, Durner M, Sander T, et al. Mutation analysis of the inwardly rectifying K (+) channels KCNJ6 (GIRK2) and KCNJ3 (GIRK1) in juvenile myoclonic epilepsy. Am J Med Genet 2000; 96: 8-11
72. Barclay J, Rees M. Mouse models of spike-wave epilepsy. Epilepsia 1999; 40 Suppl. 3: 17-22
73. Wager-Smith K, Kay SA. Circadian rhythm genetics: From flies to mice to humans. Nat Genet 2000: 26 (1): 23-7
74. Kume K, Zylka MJ, Sriram S, et al. mCRY1 and mCRY2 are essential components of the negative limb of the circadian clock feedback loop. Cell 1999: 98 (2): 193-205
75. Fleck MW, Hirotsune S, Gambello MJ, et al. Hippocampal abnormalities and enhanced excitability in a murine model of human lissencephaly. J Neurosci 2000; 20 (7): 2439-50